Approach
Team
Portfolio
Creating Value
Purpose and Values
Latest News
Get in Touch
Join us on LinkedIn
Copyright ©
Terms & Conditions
Privacy
Investor Portal
Select An Option Below to Login
NRV, NRF III and NRF IV
KNRV II
Approach
Team
Portfolio
Creating Value
Return to News
Optilogic Closes $40M Series B
April 8, 2025
Up Next
March 28, 2025
Diagnostics Market Outlook and How the FDA’s Fast Tracked Approval Process Has Helped Companies Like NOWDiagnostics
Read More
